[Tumor markers used in diagnosis and monitoring of primary bronchopulmonary carcinoma].
Pulmonary neoplasm is a serious disease, often detected in its final stages. Tumor markers, although not a diagnosis method for pulmonary neoplasms, are useful in monitoring the response to treatment and the relapses, as follows: neuron specific enolase (NSE) increases in micro-cellular neoplasm, Cyfra 21-1 increases in non-micro-cellular neoplasm, while the increase of carcino-embryonic antigen (CEA) is non-specific, as it is high in both primary and secondary lung cancer
Mahler
Beatrice
B
UMF Bucureşti, Institutul de Pneumologie Marius Nasta Bucureşti. medic_bucuresti@yahoo.com
D000951:Antigens, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood; D002283:Carcinoma, Bronchogenic / Q000097:blood / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D053539:Keratin-19; D007633:Keratins / Q000097:blood; D008175:Lung Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000628:therapy; D010751:Phosphopyruvate Hydratase / Q000097:blood; D012680:Sensitivity and Specificity
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D053539:Keratin-19; C102012:antigen CYFRA21.1; D007633:Keratins; D010751:Phosphopyruvate Hydratase